The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease
Open accessAbstract
Mitochondrial dysfunction is a prominent feature of Alzheimer's disease (AD) neurons. In this study, we explored the involvement of an abnormal mitochondrial dynamics by investigating the changes in the expression of mitochondrial fission and fusion proteins in AD brain and the potential cause and consequence of these changes in neuronal cells. We found that mitochondria were redistributed away from axons in the pyramidal neurons of AD brain. Immunoblot analysis revealed that levels of DLP1 (also referred to as Drp1), OPA1, Mfn1, and Mfn2 were significantly reduced whereas levels of Fis1 were significantly increased in AD. Despite their differential effects on mitochondrial morphology, manipulations of these mitochondrial fission and fusion proteins in neuronal cells to mimic their expressional changes in AD caused a similar abnormal mitochondrial distribution pattern, such that mitochondrial density was reduced in the cell periphery of M17 cells or neuronal process of primary neurons and correlated with reduced spine density in the neurite. Interestingly, oligomeric amyloid-beta-derived diffusible ligands (ADDLs) caused mitochondrial fragmentation and reduced mitochondrial density in neuronal processes. More importantly, ADDL-induced synaptic change (i.e., loss of dendritic spine and postsynaptic density protein 95 puncta) correlated with abnormal mitochondrial distribution. DLP1 overexpression, likely through repopulation of neuronal processes with mitochondria, prevented ADDL-induced synaptic loss, suggesting that abnormal mitochondrial dynamics plays an important role in ADDL-induced synaptic abnormalities. Based on these findings, we suggest that an altered balance in mitochondrial fission and fusion is likely an important mechanism leading to mitochondrial and neuronal dysfunction in AD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased accumulation of APP and its processed peptides in the mitochondria of AD neurons and their effects on mitochondrial dynamics and mitophagy have been documented (21–24).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial fission-fusion dynamics through alterations of Drp1, Parkin, and Pink1 functions (23,24), which play essential roles in mitophagy induction and mitochondrial quality control during healthy brain aging, are disrupted in various neurodegenerative diseases, including Parkinson’s disease (PD) and AD (25).”
From Alzheimer's Disease–Associated Amyloid-β Precursor Protein Prevents Aging Stress–Induced Mitophagy and Fumarate Depletion to Improve Antitumor Immunity (2025) · cites this paper as [24]
In the citing paper
“Aβ accumulates in mitochondria in AD brain, which is accompanied by altered mitochondrial structure, decreased mitochondrial respiratory function and ATP production, impaired mitochondrial dynamics, and elevated mitochondria-associated oxidative stress.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Mitochondrial Aβ levels correlate with abnormalities in mitochondrial structure and function.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Aβ peptides can induce ROS production from mitochondria, leading to release of cytochrome c and apoptosis-inducing factor, thereby driving mitochondrial dysfunction, cell apoptosis and neuronal loss [97, 100].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [97]
In the citing paper
“Soluble Aβ oligomers disrupted the balance between mitochondrial fission and fusion, leading to significant mitochondrial dysfunction.197,198”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [197]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Dynamin-related Protein Drp1 Is Required for Mitochondrial Division in Mammalian Cells
Smirnova, E., Griparić, L., Shurland, D., & van der Bliek, A. M. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2245 · Cited by 1,938
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses
Li, Z., Okamoto, K.-I., Hayashi, Y., & Sheng, M. (2004) · Cell · doi:10.1016/j.cell.2004.11.003 · Cited by 1,498
Cited by
Sorted by citations
Items 601–700 of 1,001
SanMartín, C. D., Adasme, T., Hidalgo, C., & Paula-Lima, A. C. (2012) · Neurodegenerative Diseases · doi:10.1159/000334901 · Cited by 37
Cho, M.-H., Kim, D., Choi, J., Chang, E., & Seung-YongYoon (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.010 · Cited by 39
Ma, Y., Song, R., & Duan, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1542369 · Cited by 39
Mind the Gap: Mitochondria and the Endoplasmic Reticulum in Neurodegenerative Diseases
Leal, N. S., & Martins, L. M. (2021) · Biomedicines · doi:10.3390/biomedicines9020227 · Cited by 40
Hesperetin Nanocrystals Improve Mitochondrial Function in a Cell Model of Early Alzheimer Disease
Babylon, L., Grewal, R., Stahr, P.-L., Eckert, R. W., Keck, C. M., & Eckert, G. P. (2021) · Antioxidants · doi:10.3390/antiox10071003 · Cited by 37
Single-Cell Spatial Proteomic Imaging for Human Neuropathology
Vijayaragavan, K., Cannon, B. J., Tebaykin, D., Bosse, M. M., Baranski, A., Oliveria, J. P., Bukhari, S. A., Mrdjen, D., Corces, M. R., McCaffrey, E., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01465-x · Cited by 40
Galindo, M. F., Solesio, M. E., Atienzar‐Aroca, S., Zamora, M. J., & Jordán, J. (2012) · Parkinson s Disease · doi:10.1155/2012/131058 · Cited by 37
Lu, L., Guo, L., Gauba, E., Tian, J., Wang, L., Tandon, N., Shankar, M., Beck, S. J., Du, Y., & Du, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144068 · Cited by 37
Lee, C. A., Chin, L., & Li, L. (2017) · Protein & Cell · doi:10.1007/s13238-017-0469-4 · Cited by 36
Stockburger, C., Eckert, S. H., Eckert, G. P., Friedland, K., & Müller, W. E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179915 · Cited by 37
H. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35
Zhou, Y., Luo, D., Shi, J.-Z., Yang, X., Xu, W., Gao, W.-P., Guo, Y., Zhao, Q., Xie, X., He, Y., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116455 · Cited by 37
Neural Metabolic Networks: Key Elements of Healthy Brain Function
Madrer, N., Perera, N. D., Uccelli, N. A., Abbondanza, A., Andersen, J. V., Carsana, E. V., Demmings, M. D., Fernandez, R. F., de Fragas, M. G., Gbadamosi, I., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70084 · Cited by 37
Bioenergetics and metabolism: a bench to bedside perspective
Swerdlow, R. H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13509 · Cited by 35
Mitochondrial calcium uniporter as a potential therapeutic strategy for Alzheimer’s disease
Venugopal, A., Iyer, M., Balasubramanian, V., & Vellingiri, B. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.39 · Cited by 35
Pathak, G. A., Zhou, Z., Silzer, T. K., Barber, R. C., & Phillips, N. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12003 · Cited by 33
Sex Differences in Biological Processes and Nitrergic Signaling in Mouse Brain
Khaliulin, I., Kartawy, M., & Amal, H. (2020) · Biomedicines · doi:10.3390/biomedicines8050124 · Cited by 35
Lee, D. G., Nam, B. R., Huh, J., & Lee, D. (2020) · Inflammation · doi:10.1007/s10753-020-01370-2 · Cited by 37
Selective Neuron Vulnerability in Common and Rare Diseases—Mitochondria in the Focus
Paß, T., Wiesner, R. J., & Pla‐Martín, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.676187 · Cited by 37
Bonda, D., Smith, M. A., Perry, G. L., Lee, H., Wang, X., & Zhu, X. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072562 · Cited by 35
Self-citationSnow, W. M., Cadonic, C., Cortes-Pérez, C. M., Adlimoghaddam, A., Chowdhury, S. R., Thomson, E. A., Anozie, A., Bernstein, M. J., Gough, K. M., Fernyhough, P., et al. (2020) · Nutrients · doi:10.3390/nu12113589 · Cited by 36
Protective effects of a small molecule inhibitor, DDQ against amyloid beta in Alzheimer’s disease
Vijayan, M., Bose, C., & Reddy, P. H. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.04.005 · Cited by 34
Zhang, R.-L., Lei, B., Wu, G., Wang, Y. Y., & Huang, Q. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106210 · Cited by 34
Potential benefits of medium chain fatty acids in aging and neurodegenerative disease
Dunn, E., Zhang, B., Sahota, V. K., & Augustin, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1230467 · Cited by 38
Dysfunction of mitochondrial dynamics in the brains of scrapie-infected mice
Choi, H.-S., Choi, Y., Shin, H., Oh, J.-M., Park, J., Kim, J., Carp, R. I., Choi, E., & Kim, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.069 · Cited by 33
Zhang, C., Shi, Z., Zhang, L., Zhou, Z., Zheng, X., Liu, G., Bu, G., Fraser, P. E., Xu, H., & Zhang, Y. (2016) · Journal of Cell Science · doi:10.1242/jcs.176792 · Cited by 33
la Fuente-Muñoz, C. E. D., & Arias, C. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0068 · Cited by 33
Characterization of Mitochondrial Dysfunction in the 7PA2 Cell Model of Alzheimer's Disease
Jakovljevic, N. K., Magnifico, M. C., Arese, M., Meli, G., Forte, E., Lecci, A., Manca, A., Giuffrè, A., Mastronicola, D., Sarti, P., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130728 · Cited by 32
Hoekstra, J. G., Cook, T. J., Stewart, T., Mattison, H. A., Dreisbach, M. T., Hoffer, Z. S., & Zhang, J. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.10.022 · Cited by 37
Park, J., Kim, B., Park, S., Jin, J., Jeon, Y., Wen, G. Y., Shin, H., Carp, R. I., & Kim, Y. (2010) · Hippocampus · doi:10.1002/hipo.20753 · Cited by 33
Giacomo, G. D., Rizza, S., Montagna, C., & Filomeni, G. (2012) · International Journal of Cell Biology · doi:10.1155/2012/361872 · Cited by 33
Atlante, A., & Valenti, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115951 · Cited by 33
Alzheimer disease as a vascular disorder: Where do mitochondria fit?
Correia, S. C., Santos, R. X., Cardoso, S., Carvalho, C., Candeias, E., Duarte, A. I., Plácido, A. I., Santos, M. S., & Moreira, P. I. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.006 · Cited by 32
Leal, M. C., Magnani, N., Villordo, S. M., Marino‐Buslje, C., Evelson, P., Castaño, E. M., & Morelli, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.424820 · Cited by 33
Wang, X., Kastanenka, K. V., Arbel‐Ornath, M., Commins, C., Kuzuya, A., Lariviere, A., Krafft, G. A., Hefti, F. F., Jerecìć, J., & Bacskai, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22979-2 · Cited by 32
Self-citationKang, S., Byun, J., Son, S. M., & Mook‐Jung, I. (2018) · Cell Death Discovery · doi:10.1038/s41420-017-0023-4 · Cited by 32
iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia
Li, L., Roh, J. H., Chang, E. H., Lee, Y. K., Lee, S., Kim, M., Koh, W., Chang, J. W., Kim, H. J., Nakanishi, M., et al. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.5.350 · Cited by 32
Sanyal, T., Paul, M., Bhattacharjee, S., & Bhattacharjee, P. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.127305 · Cited by 33
Mitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions
Mani, S., Swargiary, G., & Chadha, R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.001 · Cited by 33
Boosting mitochondrial health to counteract neurodegeneration
Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 36
Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review
Yang, X., Ma, Z., Lian, P., Xu, Y. C., & Cao, X. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1172197 · Cited by 35
Battling Alzheimer’s Disease: Targeting SUMOylation-Mediated Pathways
Martins, W. C., Tasca, C. I., & Cimarosti, H. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1681-3 · Cited by 32
Centaurin-α1-Ras-Elk-1 Signaling at Mitochondria Mediates β-Amyloid-Induced Synaptic Dysfunction
Szatmari, E. M., Oliveira, A. F., Sumner, E. J., & Yasuda, R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2641-12.2013 · Cited by 32
Skrobot, O. A., McKnight, A. J., Passmore, P., Seripa, D., Mecocci, P., Panza, F., Kalaria, R. N., Wilcock, G. K., Munafo, M. R., Erkinjuntti, T., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150862 · Cited by 33
Lavich, I. C., de Freitas, B. S., Kist, L. W., Falavigna, L., Dargél, V. A., Köbe, L. M., Aguzzoli, C. S., Piffero, B., Florian, P. Z., Bogo, M. R., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.025 · Cited by 32
Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
Casoli, T., Spazzafumo, L., Stefano, G. D., & Conti, F. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00142 · Cited by 31
The role of cell type-specific mitochondrial dysfunction in the pathogenesis of Alzheimer's disease
Kim, D., & Mook‐Jung, I. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.12.282 · Cited by 31
la Fuente-Muñoz, C. E. D., Rosas‐Lemus, M., Moreno‐Castilla, P., Bermúdez‐Rattoni, F., Uribe‐Carvajal, S., & Arias, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228727 · Cited by 31
When the Balance Tips: Dysregulation of Mitochondrial Dynamics as a Culprit in Disease
Kyriakoudi, S., Drousiotou, A., & Petrou, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094617 · Cited by 33
Mitofusin 2: A link between mitochondrial function and substrate metabolism?
Emery, J., & Ortiz, R. M. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.09.003 · Cited by 34
Dentoni, G., Castro‐Aldrete, L., Naia, L., & Ankarcrona, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.920228 · Cited by 32
Atamna, H. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9246-2 · Cited by 31
Dysfunctional Mitochondrial Dynamics in the Pathophysiology of Neurodegenerative Diseases
Haun, F., Nakamura, T., & Lipton, S. A. (2013) · Journal of Cell Death · doi:10.4137/jcd.s10847 · Cited by 34
A new method for quantifying mitochondrial axonal transport
Chen, M., Li, Y., Yang, M., Chen, X., Chen, Y., Yang, F., Lu, S., Yao, S.-Y., Zhou, T., Liu, J., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0268-3 · Cited by 35
Chen, S., Zhen, Y., Lin, J., Lin, T., Huang, C., Liou, C., Chan, S. H. H., & Chuang, Y. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12600 · Cited by 31
Sadakierska−Chudy, A., Kotarska, A., Frankowska, M., Jastrzębska, J., Wydra, K., Miszkiel, J., Przegaliński, E., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0153-3 · Cited by 32
Corrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 31
Fleck, D., Phu, L., Verschueren, E., Hinkle, T. B., Reichelt, M., Bhangale, T., Haley, B., Wang, Y., Graham, R., Kirkpatrick, D. S., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0116-19.2019 · Cited by 31
Khan, M. M., Paez, H. G., Pitzer, C. R., & Alway, S. E. (2022) · Current Neuropharmacology · doi:10.2174/1570159x05666220908100545 · Cited by 30
Massaro, M., Baudo, G., Lee, H., Liu, H., & Blanco, E. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00513 · Cited by 34
Self-citationHumanin prevents brain mitochondrial dysfunction in a cardiac ischaemia–reperfusion injury model
Kumfu, S., Charununtakorn, S. T., Jaiwongkam, T., Chattipakorn, N., & Chattipakorn, S. C. (2016) · Experimental Physiology · doi:10.1113/ep085749 · Cited by 29
Novel therapeutic approaches to target neurodegeneration
de la Fuente, A. G., Pelucchi, S., Mertens, J., Luca, M. D., Mauceri, D., & Marcello, E. E. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16078 · Cited by 32
Dementia, stroke and migraine — Some common pathological mechanisms
Sas, K., Párdutz, Á., Toldi, J., & Vécsei, L. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.001 · Cited by 30
The mechanisms and roles of mitochondrial dynamics in C. elegans
Campbell, D., & Zuryn, S. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.10.006 · Cited by 28
Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer’s disease
Wasim, R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01916-6 · Cited by 31
Improvement of mitochondrial function and dynamics by the metabolic enhancer piracetam
Stockburger, C., Kurz, C., Koch, K. A., Eckert, S. H., Leuner, K., & Müller, W. E. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130054 · Cited by 29
Mitochondria in Alzheimer’s Disease and Diabetes-Associated Neurodegeneration: License to Heal!
Cardoso, S., Correia, S. C., Carvalho, C., & Moreira, P. I. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_3 · Cited by 29
Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer’s Disease
Wu, A. J., Tong, B. C., Huang, S., Li, M., & Cheung, K. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191210091302 · Cited by 30
Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models
Woo, J., Cho, H., Seol, Y., Kim, S. H., Park, C., Yousefian-Jazi, A., Hyeon, S. J., Lee, J.-H., & Ryu, H. (2021) · Antioxidants · doi:10.3390/antiox10020229 · Cited by 32
Jin, X., Guo, J., Wang, L., Zhong, X., Yao, W., Gao, H., & Liu, M. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113401 · Cited by 31
Mitochondrial Deficits With Neural and Social Damage in Early-Stage Alzheimer’s Disease Model Mice
Misrani, A., Tabassum, S., Huo, Q., Tabassum, S., Jiang, J., Ahmed, A., Chen, X., Zhou, J., Zhang, J., Liu, S., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.748388 · Cited by 29
Shao, C., Zhu, J., Ma, X., Siedlak, S. L., Cohen, M. L., Lerner, A. J., & Wang, W. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.02.006 · Cited by 29
Vijayan, M., & Reddy, P. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158561 · Cited by 29
Mitochondrial dynamic changes in health and genetic diseases
Chen, L., Winger, A. J., & Knowlton, A. A. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3663-y · Cited by 31
Lee, D. G., Min, J., Lee, H., & Lee, D. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.07.011 · Cited by 29
Self-citationMani, S., Wasnik, S., Shandilya, C., Srivastava, V., Khan, S., & Singh, K. K. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1615764 · Cited by 33
Moulis, M., Millet, A. M. C., Daloyau, M., Miquel, M., Ronsin, B., Wissinger, B., Pelloquin, L., & Belenguer, P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13894 · Cited by 28
Amyloid-beta oligomers induce Parkin-mediated mitophagy by reducing Miro1
Kam, M. K., Lee, D. G., Kim, B., Huh, J., Lee, H. J., Park, Y., & Lee, D. (2020) · Biochemical Journal · doi:10.1042/bcj20200488 · Cited by 28
Self-citationMarmolejo-Garza, A., Medeiros-Furquim, T., Rao, R. G., Eggen, B. J. L., Boddeke, E., & Dolga, A. M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119326 · Cited by 29
Mitochondrial quality control in the brain: The physiological and pathological roles
Shen, X., Sun, P., Zhang, H., & Yang, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1075141 · Cited by 30
Xie, J., Wu, S., Szadowski, H., Min, S., Yang, Y., Bowman, A. B., Rochet, J., Freeman, J. L., & Yuan, C. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105023 · Cited by 27
Mitophagy in Neurodegeneration: An Opportunity for Therapy?
Santos, R. X., Correia, S. C., Carvalho, C., Cardoso, S., Santos, M. S., & Moreira, P. I. (2011) · Current Drug Targets · doi:10.2174/138945011795528813 · Cited by 29
Dynamin‐like protein 1 cleavage by calpain in Alzheimer’s disease
Jiang, S., Shao, C., Tang, F., Wang, W., & Zhu, X. (2019) · Aging Cell · doi:10.1111/acel.12912 · Cited by 27
Self-citationMitochondrial Reshaping Accompanies Neural Differentiation in the Developing Spinal Cord
Mils, V., Bosch, S., Roy, J., Bel-Vialar, S., Belenguer, P., Pituello, F., & Miquel, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128130 · Cited by 30
Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease
Feldhaus, P., Fraga, D. B., Ghedim, F. V., De Luca, R. D., Bruna, T. D., Heluany, M., Matos, M. P., Ferreira, G. K., Jeremias, I. C., Heluany, C., et al. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9253-y · Cited by 27
Potential Retinal Biomarkers in Alzheimer’s Disease
García-Bermúdez, M. Y., Vohra, R., Freude, K., van Wijngaarden, P., Martin, K. R. G., Thomsen, M. S., Aldana, B. I., & Kolko, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115834 · Cited by 30
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Yip, J., Chiang, G. S. H., Lee, I. C. J., Lehming-Teo, R., Dai, K., Dongol, L., Wang, L. Y.-T., Teo, D. W. X., Seah, G. T., & Lehming, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010364 · Cited by 30
Qin, S.-L., Deng, J. V., Lou, D., Yu, W., Pei, J.-J., & Guan, Z. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.06.001 · Cited by 27
Pakpian, N., Phopin, K., Kitidee, K., Govitrapong, P., & Wongchitrat, P. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201006162538 · Cited by 28
Salam, S., Tacconelli, S., Smith, B. N., Mitchell, J. C., Glennon, E. B. C., Nikolaou, N., Houart, C., & Vance, C. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93189-6 · Cited by 27
Latest assessment methods for mitochondrial homeostasis in cognitive diseases
You, W., Li, Y., Liu, K., Mi, X., Li, Y., Guo, X., & Li, Z. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382222 · Cited by 28
Liu, Y., Sparatore, A., Soldato, P. D., & Bian, J. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.01.023 · Cited by 26
Studying tauopathies in Drosophila: A fruitful model
Sun, M., & Chen, L. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.03.029 · Cited by 27
Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease
Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1205488 · Cited by 27
Feng, T., Yamashita, T., Zhai, Y., Shang, J., Nakano, Y., Morihara, R., Fukui, Y., Hishikawa, N., Ohta, Y., & Abe, K. (2018) · Brain Research · doi:10.1016/j.brainres.2018.06.003 · Cited by 27
Role of endolysosomes and inter-organellar signaling in brain disease
Afghah, Z., Chen, X., & Geiger, J. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104670 · Cited by 27
Effects of sulforaphane on brain mitochondria: mechanistic view and future directions
Jardim, F. R., de Almeida, F. J. S., Luckachaki, M. D., & de Oliveira, M. R. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1900614 · Cited by 26
Mitochondrial dynamics in neurological diseases: a narrative review
Shen, Y. G., Jiang, W., Li, X., Cao, A., Li, D. X., Li, S., Yang, J., & Jiao, Q. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-2401 · Cited by 26
Self-citationHarnessing BDNF Signaling to Promote Resilience in Aging
Faraji, J., & Metz, G. A. S. (2024) · Aging and Disease · doi:10.14336/ad.2024.0961 · Cited by 29
Wang, Y., Wu, F., Pan, H., Zheng, W., Feng, C. T., Wang, Y., Deng, Z., Wang, L., Luo, J., & Chen, S. (2016) · Scientific Reports · doi:10.1038/srep22244 · Cited by 26
Metadata
- Authors
- Wang, X., Su, B., Lee, H.-G., Li, X., Perry, G., Smith, M. A., & Zhu, X.
- Affiliations
- Case Western Reserve University (US)
- The University of Texas at San Antonio (US)
- Venue
- Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-07-15
- Volume
- 29
- Issue
- 28
- Pages
- 9090-9103
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2735241
- OpenAlex
- W2089141103
- Cited by
- 1,224
- References
- 50
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 71 · 2023: 92 · 2022: 77 · 2021: 102 · 2020: 83 · 2019: 71 · 2018: 60 · 2017: 75 · 2016: 67 · 2015: 59 · 2014: 57 · 2013: 58 · 2012: 84
- FWCI
- 29.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association (AG031852, IIRG-07-60196)
- National Institutes of Health (IIRG-07-60196)
- National Institute on Aging (AG 031852, R01AG031852)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Alzheimer's disease, mitochondrial dynamics, mitochondrial fission, mitochondrial fusion, Drp1, OPA1, Mfn1, mitofusin 2, Fis1, mitochondrial distribution, axons, pyramidal neurons, synaptic loss, dendritic spines, PSD-95, mitochondrial dysfunction
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Animals, Antibodies, Monoclonal, Biotin, Cells, Cultured, Embryo, Mammalian, Gene Expression Regulation, Hippocampus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Middle Aged, Mitochondria, Mutation, Neuroblastoma, Neurons, Postmortem Changes, Time Factors, Transfection, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, GTP Phosphohydrolases, Mitochondrial Proteins, Membrane Transport Proteins, Mitochondrial Membrane Transport Proteins, Dynamins, Green Fluorescent Proteins, Rats, Cyclooxygenase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
